江南·体育(JN SPORTS)官方网站,江南体育app下载

|
|
EN

  • 业务咨询

    中国：

    Email: marketing@hangzhouaijunshengwu.com

    业务咨询专线：400-780-8018

    （仅限服务咨询，其他事宜请拨打川沙总部电话）

    川沙总部电话: +86 (21) 5859-1500

    海外：

    +1(626)986-9880(U.S. - West Coast)

    0044 7790 816 954 (Europe)

    Email:marketing@medicilon.com
在线留言×
点击切换
Customer Center
客户中心

研究人员成功发现了一种口服PROTAC降解剂SIAIS164018，具有良好的体内耐受性。PK和MTD研究通过美迪西进行

2023-07-06
|
访问量：

PROTAC is an attractive technology in drug discovery. Researchers successfully discovered an orally available PROTAC degrader SIAIS164018 which degrades not only ALK or mutant EGFR but also oncoproteins involved in metastasis. SIAIS164018 is orally bioavailable and well tolerated in vivo. Pharmacokinetic and maximal tolerated dose (MTD) assays were performed by Medicilon.

59.png

Reference:

Chaowei Ren, et al. Discovery of a Brigatinib Degrader SIAIS164018 with Destroying Metastasis-Related Oncoproteins and a Reshuffling Kinome Profile. J Med Chem. 2021 Jul 8;64(13):9152-9165. doi: 10.1021/acs.jmedchem.1c00373. 


相关新闻
江南·体育(JN SPORTS)官方网站